These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21929909)

  • 1. Hunterian Lecture. Characterisation of human prostate epithelial progenitor differentiation in response to androgens.
    Heer R
    Ann R Coll Surg Engl; 2011 Sep; 93(6):424-8. PubMed ID: 21929909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of androgen in determining differentiation and regulation of androgen receptor expression in the human prostatic epithelium transient amplifying population.
    Heer R; Robson CN; Shenton BK; Leung HY
    J Cell Physiol; 2007 Sep; 212(3):572-8. PubMed ID: 17541959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen deprivation causes truncation of the C-terminal region of androgen receptor in human prostate cancer LNCaP cells.
    Harada N; Inoue K; Yamaji R; Nakano Y; Inui H
    Cancer Sci; 2012 Jun; 103(6):1022-7. PubMed ID: 22360658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human α(2)β(1)(HI) CD133(+VE) epithelial prostate stem cells express low levels of active androgen receptor.
    Williamson SC; Hepburn AC; Wilson L; Coffey K; Ryan-Munden CA; Pal D; Leung HY; Robson CN; Heer R
    PLoS One; 2012; 7(11):e48944. PubMed ID: 23145034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A competitive inhibitor that reduces recruitment of androgen receptor to androgen-responsive genes.
    Cherian MT; Wilson EM; Shapiro DJ
    J Biol Chem; 2012 Jul; 287(28):23368-80. PubMed ID: 22589544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HEXIM1 plays a critical role in the inhibition of the androgen receptor by anti-androgens.
    Yeh IJ; Song K; Wittmann BM; Bai X; Danielpour D; Montano MM
    Biochem J; 2014 Sep; 462(2):315-27. PubMed ID: 24844355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inter-related in vitro effects of androgens, fatty acids and oxidative stress in prostate cancer: a mechanistic model supporting prevention strategies.
    Lin H; Lu JP; Laflamme P; Qiao S; Shayegan B; Bryskin I; Monardo L; Wilson BC; Singh G; Pinthus JH
    Int J Oncol; 2010 Oct; 37(4):761-6. PubMed ID: 20811696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen suppresses proliferation of castration-resistant LNCaP 104-R2 prostate cancer cells through androgen receptor, Skp2, and c-Myc.
    Chuu CP; Kokontis JM; Hiipakka RA; Fukuchi J; Lin HP; Lin CY; Huo C; Su LC; Liao S
    Cancer Sci; 2011 Nov; 102(11):2022-8. PubMed ID: 21781227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced antiproliferative and proapoptotic effects on prostate cancer cells by simultaneously inhibiting androgen receptor and cAMP-dependent protein kinase A.
    Desiniotis A; Schäfer G; Klocker H; Eder IE
    Int J Cancer; 2010 Feb; 126(3):775-89. PubMed ID: 19653278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase as an important target of androgen signaling blockade for prostate cancer treatment.
    Liu S; Qi Y; Ge Y; Duplessis T; Rowan BG; Ip C; Cheng H; Rennie PS; Horikawa I; Lustig AJ; Yu Q; Zhang H; Dong Y
    Mol Cancer Ther; 2010 Jul; 9(7):2016-25. PubMed ID: 20571066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive auto-regulation of androgen receptor provides a paradigm shifting rationale for bipolar androgen therapy (BAT) for castrate resistant human prostate cancer.
    Isaacs JT; D'Antonio JM; Chen S; Antony L; Dalrymple SP; Ndikuyeze GH; Luo J; Denmeade SR
    Prostate; 2012 Oct; 72(14):1491-505. PubMed ID: 22396319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Androgens stimulate the expression of SOCS-3 and inhibits their effect on proliferation and secretion].
    Neuwirt H; Puhr M; Cavarretta IT; Mitterberger M; Hobisch A; Culig Z
    Aktuelle Urol; 2009 Aug; 40(4):231-4. PubMed ID: 19634073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin represses androgen-dependent and androgen-independent prostate cancers by targeting androgen receptor.
    Wang Y; Liu G; Tong D; Parmar H; Hasenmayer D; Yuan W; Zhang D; Jiang J
    Prostate; 2015 Aug; 75(11):1187-96. PubMed ID: 25894097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of treatment with androgen receptor ligands on microRNA expression of prostate cancer cells.
    Segal CV; Koufaris C; Powell C; Gooderham NJ
    Toxicology; 2015 Jul; 333():45-52. PubMed ID: 25846647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of androgen receptor in the progression of human prostate tumor cells to androgen independence and insensitivity.
    Kokontis JM; Hsu S; Chuu CP; Dang M; Fukuchi J; Hiipakka RA; Liao S
    Prostate; 2005 Dec; 65(4):287-98. PubMed ID: 16015608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells.
    Pandini G; Mineo R; Frasca F; Roberts CT; Marcelli M; Vigneri R; Belfiore A
    Cancer Res; 2005 Mar; 65(5):1849-57. PubMed ID: 15753383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP.
    Swinnen JV; Esquenet M; Goossens K; Heyns W; Verhoeven G
    Cancer Res; 1997 Mar; 57(6):1086-90. PubMed ID: 9067276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen up-regulates vascular endothelial growth factor expression in prostate cancer cells via an Sp1 binding site.
    Eisermann K; Broderick CJ; Bazarov A; Moazam MM; Fraizer GC
    Mol Cancer; 2013 Feb; 12():7. PubMed ID: 23369005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of FGF8 expression by the androgen receptor in human prostate cancer.
    Gnanapragasam VJ; Robson CN; Neal DE; Leung HY
    Oncogene; 2002 Aug; 21(33):5069-80. PubMed ID: 12140757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological properties of androgen receptor pure antagonist for treatment of castration-resistant prostate cancer: optimization from lead compound to CH5137291.
    Kawata H; Arai S; Nakagawa T; Ishikura N; Nishimoto A; Yoshino H; Shiraishi T; Tachibana K; Nakamura R; Sato H
    Prostate; 2011 Sep; 71(12):1344-56. PubMed ID: 21308717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.